Showing results (461-470 of 1,071) with videos related to

Sort By:
Pageof 108
Oncoimmunology|November 18, 2017
Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomesYu Wang, Ying-Jun Chang, Lu Chen, et al.
Neuromuscular Disorders : NMD|February 10, 2019
Congenital disorder of glycosylation type 1T with a novel truncated homozygous mutation in PGM1 gene and literature reviewWo-Tu Tian, Xing-Hua Luan, Hai-Yan Zhou, et al.
Functional & Integrative Genomics|February 15, 2018
Integrated mRNA and miRNA profiling revealed deregulation of cellular stress response in bone marrow mesenchymal stem cells derived from patients with immune thrombocytopeniaJia-Min Zhang, Xiao-Lu Zhu, Jing Xue, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 31, 2008
[The significance of serial monitoring of bcr-abl transcripts levels after allogeneic hematopoietic stem cell transplantation in screening chronic myeloid leukemia patients with low relapse]Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantationXiao-Jun Huang, Dai-Hong Liu, Kai-Yan Liu, et al.
Medicine|December 17, 2020
Prognostic significance of SET-NUP214 fusion gene in acute leukemia after allogeneic hematopoietic stem cell transplantationMeng-Ge Gao, Yan Hong, Ya-Zhen Qin, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 5, 2015
Polymorphisms in genes of the de novo lipogenesis pathway and overall survival of hepatocellular carcinoma patients undergoing transarterial chemoembolizationYou-Sheng Wu, Deng-Ke Bao, Jing-Yao Dai, et al.
Annals of Hematology|February 9, 2023
Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?Pei-Hua Wu, Wen-Xuan Huo, Xiao-Dong Mo, et al.
Annals of Hematology|November 27, 2019
The predictive value of minimal residual disease when facing the inconsistent results detected by real-time quantitative PCR and flow cytometry in NPM1-mutated acute myeloid leukemiaMeng-Ge Gao, Guo-Rui Ruan, Ying-Jun Chang, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 16, 2020
Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation Compared With Chemotherapy as Postremission Treatment of Children With Intermediate-risk Acute Myeloid Leukemia in First Complete RemissionYu-Juan Xue, Yi-Fei Cheng, Ai-Dong Lu, et al.
Pageof 108